Pharmacologic Management of ADHD

Similar documents
Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6

Parents Guide to ADHD Medications. Copyright Child Mind Institute

AD/HD is a mental disorder, and it often lasts from

ADHD Medications: Basics. David Benhayon MD, PhD

The Use of ADHD Medication in the Pediatric Population

Dose Range. Dose Schedule. Child: 5-60 mg Over 50 kg:5-100 mg Focalin, child: mg Over 50 kg: mg. Focalin: 4-5 hrs.

What are the most common signs of ADHD? And what are the most common medication interventions?

Options for Medication Management: Rx and OTC/Natural Treatments AMY NEWMEYER MD CHKD DIVISION OF DEVELOPMENTAL PEDIATRICS MARCH 24, 2018.

Drug Class Review. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

Behavioral Health. Behavioral Health. Prescribing Guidelines

Humberto Nagera M.D. Director, The Carter-Jenkins Center Psychoanalyst, Children, Adolescents and Adults Professor of Psychiatry at USF Professor

Psychiatric Medications. Positive and negative effects in the classroom

ADHD Medications Table

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Treating Disruptive Behavior Disorders in Children and Teens. A Review of the Research for Parents and Caregivers

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy

35 mg NF -- Dextroamphetamine Sulfate IR Tablets: Zenzedi IR Ttablets: Dextroamphetamine Sulfate ER Capsules: 15 mg ProCentra Solution.

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Facts about ADHD drugs as treatment

Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information

ADHD: A Focus On Drug Therapy

See Important Reminder at the end of this policy for important regulatory and legal information.

ADHD: Management Update

Trouble shooting medication adjustment and side effect management in children with ADHD

PL CE LIVE February 2011 Forum

Central Nervous System Stimulants Drug Class Prior Authorization Protocol

Conroe ADHD Solutions

Child/Adolescent Attention-Deficit/Hyperactivity Disorder

Psychopharmacology for Treatment of ADHD and ADHD with other co-existing psychiatric condition

Practical Psychopharmacology for More Complex Mental Health Presentations

Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

ADHD Explanation 5: Medications used in ADHD

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center

Child/Adolescent Attention-Deficit/Hyperactivity Disorder

Half life of focalin xr

Child & Adolescent Psychiatry (a brief overview)

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center

Perspective Truth on ADHD & Medications. Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry

Attention Deficit Hyperactivity Disorder State of the Art. Christopher Okiishi, MD

A REVIEW OF STIMULANTS FOR ADHD FOR THE PRIMARY CARE PROVIDER JAMES C. ASHWORTH MD MEDICAL DIRECTOR UNIVERSITY OF UTAH NEUROPSYCHIATRIC INSTITUTE

MRCPsych Pharmacology of ADHD treatment. Dr Xanthe Barkla, Consultant Child and Adolescent Psychiatrist

Focalin compared to concerta

Psychopharmacology of ADHD. Copyright 2006 Neuroscience Education Institute. All rights reserved.

Recognition and Treatment of ADHD in Primary Care Settings. Disclosure 11/6/2013. Objectives

Methylphenidate also has an off-label indication for depression, although published trials are limited in size and duration (14).

Methylphenidate Dexmethylphenidate

Individuals with attention-deficit/hyperactivity

2013 Virtual AD/HD Conference 1

Pharmacy Prior Authorization Clinical Guideline for Attention Deficit Disorder/Attention Deficit Hyperactivity CNS Stimulants

ADHD PRIMARY CARE PRINCIPLES FOR CHILD MENTAL HEALTH 27

Individuals with attention-deficit/hyperactivity

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications

Ask The Shrink: ADHD

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

Methylphenidate Dexmethylphenidate

Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications

Attention Deficit Hyperactivity Disorder (ADHD) BY MARK FABER M.D.

Lisa Goldstein, MD Child and Adolescent and Adult Psychiatrist

Attention Deficit Hyperactivity Disorder: Comparison of Medication Efficacy and Cost

Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications

Individuals with attention-deficit/hyperactivity

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

ADHD Stimulant Step Therapy Program

Attention Deficit Hyperactivity Disorder in Children and Adults

Psychostimulant and non-stimulant agents address the symptoms of ADHD, substantial evidence shows

PEDIATRIC PHARMACOTHERAPY

The Adolescent with ADHD: Managing Transition

11/11/2018. The ABCs of Medication Management for Autism Spectrum Disorder. ABC Logging (FBA) First. ABC Logging HOW TO COMPLEMENT BEHAVIORAL THERAPY

A Physician's Perspective

Overview of ADHD Symptoms in ID/D

4/11/2018. Attention Deficit Hyperactivity Disorder. ADHD is not a real disorder. History of ADHD and Stimulants. Disclosure.

Ritalin mg equal to adderall

Medications in Autism: What We Know and Don't Know

Conversion table methylphenidate to vyvanse

11 th Annual Pacer Symposium on Children s Mental Health

Schedule FDA & literature based indications

Page: 1 of 5. Methylphenidate also has an off-label indication for depression, although published trials are limited in size and duration (12).

Presented by the National Resource Center on ADHD

Contents Definition and History of ADHD Causative Factors

It Ain t Always About Pain. MNA Pharmacology Summit Tupelo, Mississippi Sueanne Davidson DNP FNP-BC

Cerebral Stimulant and ADHD Drugs Prior Authorization Request

Creating Partnerships. Laine Young-Walker, MD

The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD

Management of Pediatric Attention Deficit & Hyperactivity Disorder (ADHD) Clinical Practice Guideline MedStar Health

To Give or not to Give Medication: That is the Question

Conversion from focalin xr to vyvanse

Evaluation and Treatment of ADHD An Overview

ADHD Part II: Managing Comorbities

UnitedHealthcare Pharmacy Clinical Pharmacy Programs. Program Number 2017 P Prior Authorization/Notification CNS Stimulants

OVERVIEW FOOD AND DRUG ADMINISTRATION-APPROVED INDICATIONS

Adderall therapeutic range

Clonidine for mood The Borg System is 100 % Retrievable & Reusable Clonidine for mood

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

We ll Be Discussing. Pregnancy 4/24/2013

ADHD Medications. Medication for ADHD: What you need to know. Are ADHD Drugs Right for You or Your Child?

ADHD:Updates and Practical Suggestions

Transcription:

Pharmacologic Management of ADHD CHADD Presentation April 13, 2015 Peter J Chung, MD, FAAP Developmental-Behavioral Pediatrician* Assistant Clinical Professor of Pediatrics University of California Irvine

I have no conflicts of interest or disclosures I will briefly discuss some off-label use of medications * Not a biochemist *Just one guy

Outline When to start medications? First line versus second line therapy Pros and cons Differences between types The decision making process Complementary and alternative medication choices Frequently Asked Questions

Outline When to start medications? First line versus second line therapy Pros and cons Differences between types The decision making process Complementary and alternative medication choices Frequently Asked Questions

American Academy of Pediatrics Practice Guidelines Children aged 4-5 years Evidence-based parent and teacher behavior therapy Medication (stimulants) if therapy does not help enough Children 6-11 years Parent and teacher therapy or/and medications (preferably both) Adolescents 12-18 years Medications with or without behavior therapy Adults?

Image from http://www.psychedconsult.com/uploads/5/5/2/7/5527771/5699388_orig.jpg

Outline When to start medications? First line versus second line therapy Pros and cons Differences between types The decision making process Complementary and alternative medication choices Frequently Asked Questions

First Line: Stimulants Drug family first developed in 1940s First line of treatment for ADHD Effect size 1.0 compared to second line treatments (0.7) Main two classes: methyphenidate (e.g. Ritalin) and mixed amphetamine salts (e.g. Adderall) Basically all provide same medication in different packaging

How they work Image credit: ADHD Institute

Pharmacokinetics Kimko HC, Cross JT, Abernethy DR. Pharmacokinetics and Clinical Effectiveness of Methylphenidate. Clinical Pharmacokinetics, Dec 1999;37(6):457-70.

Mechanisms of Delivery-- Wax Matrix Ritalin SR Metadate ER Methylin ER

Mechanisms of Delivery-- OROS Concerta Methylphenidate -OROS Alza s Osmotic Controlled Release Oral Delivery System (OROS) Image credit: Medscape

Mechanisms of Delivery-- Beads Adderall XR Focalin XR Ritalin LA Metadate CD Quillivant Image credit: Medscape

Mechanisms of Delivery--Prodrug Vyvanse

Mechanisms of Delivery-- Transdermal Image credit: Medscape

On the horizon: Delayed and Extended Release Methylphenidate Benjorna Taken in evening Begins working in about 8 hours (?) Effects last 8-10 hours (?) www.highlandtherapeutics.com

Stimulants at a glance Medication Formulation Duration of Action (hrs) Ritalin IR Tablet 3-4 Focalin IR Tablet 4-6 Methylin IR Tablet 3-4 Metadate ER Wax matrix 6-8 Ritalin SR Wax matrix 4-8 Ritalin LA Extended release beads 8-10 Quillivant XR Extended release beads (liquid) 8-12 Focalin XR Extended release beads 6-10 Concerta OROS 10-12 Metadate CD Extended release beads 8-10 Adderall IR Tablet 4-6 Adderall XR Extended release beads 8-12 Vyvanse Capsule (pro-drug) 10-12 Daytrana Patch 10-12

Combining Stimulants Long-acting stimulants can be combined with short-acting stimulants for certain cases (usually older children) Short-acting medication designed to simulate an extra ½ dose of the long-acting Typically dosed before the long-acting medication wears off

Pros and Cons: Stimulants Pros Effective Quick on/off (same day results) Easily adjusted Easily stopped Cons Work only during daytime/school hours Controlled substance Abuse/diversion potential Side effects

Side effects: Stimulants Common Headaches, stomachaches Decreased appetite Sleep problems Emotional lability (as medication wears off) Uncommon Hallucinations and psychosis Heart rate or blood pressure increase Unclear Increased Tics Increased anxiety Diminished growth (1-3 cm total) versus delayed growth? Heart rhythm problems?

Cardiac Warnings Unclear if stimulant medications increase risk of sudden death (conflicting recommendations from the American Academy of Pediatrics, the American Academy of Child and Adolescent Psychiatry, and the American Heart Association) Inquire about family history of congenital cardiac disease, hypertrophic cardiomyopathy, and sudden cardiac death (rhythm abnormalities) Consider cardiac clearance work-up if concerns on exam or history

Overtreatment Over-focused Sad Tired Like a zombie

Second Line Treatments Alpha-2 Agonist Drug family first developed in 1970s Initially developed as blood pressure medication Benefits on hyperactivity and inattention May cause rebound hypertension if stopped suddenly Guanfacine and clonidine (Tenex, Intuniv, Kapvay, Catapress) Atomoxetine (Strattera) Developed in 21 st century Selective norepinephrine reuptake inhibitor (SNRI)

Pros and Cons: Second Line Treatments Pros Less side effects Not controlled substances Longer coverage throughout day Possible additional benefits on other symptoms (tics, aggression, anxiety) Cons Longer time to effect Less dramatic/obvious results Harder to start/stop (e.g. during holidays or weekends) Side effects

Side effects: Alpha-2 Agonists Common Sleepiness Constipation Dry eyes and mouth Uncommon Irritability Low blood pressure

Side effects: Atomoxetine Common Decreased appetite Sleepiness Sexual dysfunction Constipation Dry eyes and mouth Uncommon Liver inflammation Suicidal thoughts Heart problems

Outline When to start medications? First line versus second line therapy Pros and cons Differences between types The decision making process Complementary and alternative medication choices Frequently Asked Questions

Deciding to Try Medications Child s age Child s ADHD symptoms Child s other symptoms (depression, anxiety, learning problems) School and home environment Parental readiness

Which Medication Is Best? Needs for attention during the day How long does he/she go to school? What time is homework? What other demands does the child/family have? What are the child s other symptoms? Can the child swallow a pill? What has worked for any family members? Side effects differ on drug and even sometimes by manufacturer Pharmacogenomic testing? Trial and error

Case Examples 5 year old boy attending preschool under an IEP with impulsive and aggressive behaviors inhibiting his learning Short-acting stimulant versus alpha-2 agonist 16 year old high school student who also plays baseball in the afternoon Vyvanse +/- Adderall IR in the afternoon

General Treatment Algorithm: First Line 1. Pick a stimulant, any stimulant (covered and available is best) based on length of needs. -usually start with long-acting dose unless very young 2. Increase the stimulant to max tolerated dose (can increase after 2-4 days per dose) -generally speaking, community clinicians under-dose medication when compared to research clinicians 3. Once optimal dose is achieved, monitor for side effects (every 3 months) and effectiveness via teacher, parent, or self report (at least annually). 1. Heart rate, blood pressure 2. Weight and height 3. Behavioral side effects

Dealing with side effects: stimulants Encourage lifestyle modifications Afternoon meltdowns: emotional cooldown period in afternoon Sleep problems: Sleep hygiene Low appetite: increased calories Take breaks on the weekends and holidays Usually for low appetite No evidence to suggest improvement Decrease the dose and add a second line medication Add another medication to treat side effects Try a different medication

Dealing with failure: stimulants 1. Switch medication to another stimulant (move between classes of stimulants) -~70% of children will respond to first drug, ~70% of initial non-responders respond to second drug 2. If no effective stimulant in 3 tries, move to nonstimulant options -Can use stimulant and alpha-2 agonist together

General Treatment Algorithm: Second Line 1. Start at initial dose and maintain for one month. 2. Increase dose gradually to max tolerated dose (over one month). 3. Monitor for side effects (every 3-4 months) and effectiveness via teacher, parent, or self report (at least annually).

Treatment Failure Rarely due to lack of any response Often failure is driven by side effects Consider general health issues (SLEEP) Re-consider alternative diagnoses (e.g. Autism Spectrum Disorder, Anxiety, Post-Traumatic Stress Disorder, Learning Disorder, Bipolar Disorder)

Outline When to start medications? First line versus second line therapy Pros and cons Differences between types The decision making process Complementary and alternative medication choices Frequently Asked Questions

Fish Oil / Omega 3 Fatty Acids www.vayarin.com

Fish Oil / Omega 3 Fatty Acids Mild benefit seen in research studies Exact dose and formulation not clear Tolerance and compliance is an issue Long-term treatment (not immediate results) Prescription strength available (Vayarin)

Restricted Diets (e.g. Feingold) In general, available research on special diets is limited Effect sizes/improvements typically small Most effects seen in parent-report, not teacher report No harm in restricted diet (but requires parent energy and commitment)

Biofeedback Some research studies have shown mild improvement Not enough long-term studies to demonstrate sustained improvement Not enough research to determine dose length or intensity Not covered by insurance (can be very costly)

Complementary approaches in general Effects are going to be gradual and subtle Generally 3 months should be sufficient for a trial Use blinded reporters ABAB withdrawal https://www.osep-meeting.org/2012conf/largegroup/tues_singlecaseresearchosepprojects/statanalysis.htm

Outline When to start medications? First line versus second line therapy Pros and cons Differences between types The decision making process Complementary and alternative medication choices Frequently Asked Questions

Won t he get addicted? Estimate 15-25% of substance abusers have ADHD Adults with ADHD twice as likely to be substance abusers Substance users with ADHD abuse earlier and more often than those without ADHD Self-medication versus complication of disorder Stimulant treatment does not increase risk of future substance abuse (and may decrease it)

Why can t I just give him coffee? Caffeine may produce similar benefits Benefits are generally milder Caffeine content varies per cup of coffee Dosing and length of effect are difficult to control Caffeine has other side effects

Does he have to take this forever? Brains change over time, but so do expectations and demands Adult ADHD rates 4-5% (less than childhood ADHD rates of 5-11%) ~50% of children with ADHD will retain the diagnosis as adults (?) Rates of adults with ADHD on treatment roughly <50% Increased rates of marriage problems, school problems, job difficulties, problems with law, and quality of life

What if he abuses the medication? Long-acting stimulants generally do not provide the high due to delayed release It is difficult to adjust the way the medication is taken to increase the rate of absorption (e.g. crushing and snorting) Diversion is much more of a concern than abuse

Thank you!